Microvascular Thrombi in COVID-19 – American College of Cardiology

Quick Takes Coagulopathy in patients with severe coronavirus disease 2019 (COVID-19) is associated with increased mortality and characterized by increased D-dimer, increased lactate dehydrogenase, mild thrombocytopenia, elevated fibrinogen, and elevated von Willebrand factor (VWF). Diffuse pulmonary microvascular thrombi have been observed in autopsy…

Read the full article here

Related Articles